Fundz

Proteas Bioanalytics Inc. reported raising $365,000 in an initial SEC Form D filing, from an offering of $4 Million

PRIVATENov 09, 2020

Amount Raised

$365,000

$365,000 sold, per SEC Form D (first sale Nov 9, 2020)

Round Type

Seed

TorranceInformation Technology

Who to call at Proteas Bioanalytics, and when

A new round usually means Proteas Bioanalytics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Proteas Bioanalytics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Proteas Bioanalytics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Proteas Bioanalytics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Proteas Bioanalytics

Location

Biolabs at the Lundquist Institute

Torrance, California, United States

About

From a single drop of blood, Proteas Bioanalytics is able to detect the presence of human diseases at their earliest stage, before the onset of symptoms. Our technologies will also provide objective guidance to implement effective treatment options. Proteas Bioanalytics has also developed advanced technologies for the in-depth analysis and biological understanding of single cells and tissue biopsy specimens that complement and validates our blood-based analysis platform. The field of blood and single-cell proteomics offers a tremendous opportunity to reshape the diagnosis and treatment of almost all diseases. Currently used proteomics technologies do not meet the stringent FDA performance criteria due to the high complexity and heterogeneity of human blood, tissue and cells and their analysis method.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Proteas Bioanalytics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts5 people are listed at Proteas Bioanalytics. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Proteas Bioanalytics's next move

See what Strategic adds

Proteas Bioanalytics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.